Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) EBIT Margin (2023 - 2025)

Historic EBIT Margin for Zenas BioPharma (ZBIO) over the last 3 years, with Q1 2025 value amounting to 373.3%.

  • Zenas BioPharma's EBIT Margin changed N/A to 373.3% in Q1 2025 from the same period last year, while for Sep 2025 it was 1337.97%, marking a year-over-year change of. This contributed to the annual value of 3277.76% for FY2024, which is 32034700.0% down from last year.
  • As of Q1 2025, Zenas BioPharma's EBIT Margin stood at 373.3%.
  • Over the past 5 years, Zenas BioPharma's EBIT Margin peaked at 71.25% during Q3 2023, and registered a low of 1112.46% during Q4 2024.
  • Its 3-year average for EBIT Margin is 471.5%, with a median of 373.3% in 2025.